Medicine and Dentistry
Patient
100%
Inpatient
68%
Stent
44%
Drug-Eluting Stent
39%
Percutaneous Coronary Intervention
37%
Acute Heart Infarction
31%
Lesion
26%
Myocardial Infarction
22%
Coronary Artery Disease
21%
Combination Therapy
21%
ST Segment Elevation Myocardial Infarction
21%
Follow up
18%
Analysis
16%
Rapamycin
15%
Hazard Ratio
14%
Antiplatelet
14%
Diabetes Mellitus
13%
Stenting
13%
Everolimus
11%
Association
11%
Revascularization
11%
Chronic Total Occlusion
10%
Clopidogrel
10%
Primary Percutaneous Coronary Intervention
9%
Paclitaxel
9%
Major Adverse Cardiac Event
9%
Heart Death
9%
Cardiovascular Disease
9%
Incidence
8%
Target Lesion Revascularization
8%
Acute Coronary Syndrome
8%
Hypertension
8%
Stent Thrombosis
8%
Death
8%
Left Coronary Artery
7%
Coronary Artery Obstruction
7%
Restenosis
7%
Cardiovascular System
7%
Fractional Flow Reserve
7%
Cilostazol
7%
Mortality
7%
Intravascular Ultrasound
7%
Drug
7%
Chemotherapeutic Agent
7%
Target Lesion
7%
Arteriosclerosis Obliterans
6%
Coronary Artery Bypass Graft
6%
Zotarolimus
6%
Diabetes
6%
Metal
6%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
24%
Acute Heart Infarction
22%
Stent
20%
Sirolimus
15%
Heart Infarction
13%
Anticoagulant Agent
12%
Everolimus
9%
ST Segment Elevation Myocardial Infarction
8%
Zotarolimus
8%
Paclitaxel
8%
Hypertension
7%
Clopidogrel
7%
Coronary Artery Disease
7%
Heart Death
6%
Coronary Artery Obstruction
6%
Cilostazol
6%
Statin (Protein)
6%
Rosuvastatin
6%
Diabetes Mellitus
5%
Death
5%
Blindness
5%
Nursing and Health Professions
Acute Heart Infarction
9%
Percutaneous Coronary Intervention
8%
Drug Eluting Stent
7%
Patient
6%
Clinical Outcome
6%
Clopidogrel
6%
ST Segment Elevation Myocardial Infarction
5%
Diabetes Mellitus
5%
Analysis
5%
Hypertension
5%
